Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...

Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors (CGMs) ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...

Henry Schein (NASDAQ:HSIC – Get Free Report) had its price target upped by equities researchers at Jefferies Financial Group ...